ATAI
Atai Life Sciences Nv
$1.98
Earnings Summary
Revenue | $0.02Mn |
Net Profits | $-18.29Mn |
Net Profit Margins | -101622.22% |
Highlights
Atai Life Sciences Nv’s revenue fell -52.63% since last year same period to $0.02Mn in the Q4 2023. On a quarterly growth basis, Atai Life Sciences Nv has generated -79.31% fall in its revenue since last 3-months.
Atai Life Sciences Nv’s net profit jumped 59.64% since last year same period to $-18.29Mn in the Q4 2023. On a quarterly growth basis, Atai Life Sciences Nv has generated -141.34% fall in its net profits since last 3-months.
Atai Life Sciences Nv’s net profit margin jumped 14.8% since last year same period to -101622.22% in the Q4 2023. On a quarterly growth basis, Atai Life Sciences Nv has generated -299.83% fall in its net profit margins since last 3-months.
Earnings per share (EPS) Estimates
Earnings per share (EPS) estimates of the Atai Life Sciences Nv post its latest quarter earnings
EPS Estimate Current Quarter | -0.18 |
EPS Estimate Current Year | -0.18 |
Highlights
Atai Life Sciences Nv’s earning per share (EPS) estimates for the current quarter stand at -0.18 - a -12.5% fall from last quarter’s estimates.
Atai Life Sciences Nv’s earning per share (EPS) estimates for the current year stand at -0.18.
Key Ratios
Key ratios of the Atai Life Sciences Nv post its Q1 2024 earnings
Earning Per Share (EPS) | 0 |
Highlights
Atai Life Sciences Nv’s earning per share (EPS) jumped 100% since last year same period to 0 in the Q1 2024. This indicates that the Atai Life Sciences Nv has generated 100% annual rate of jump in its earning per share (EPS) in the last 4 quarters.
Earnings Calendar
| Earnings Date | Estimated EPS | Reported EPS | Surprise % |
|---|---|---|---|
2024-05-07 | -0.18 | 0 | 100% |
₹0 US Stocks a/c Opening Fee